Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

http://www.wikidata.org/entity/Q37279999

about

One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease Checking the STEP-Associated Trafficking and Internalization of Glutamate Receptors for Reduced Cognitive Deficits: A Machine Learning Approach-Based Cheminformatics Study and Its Application for Drug Repurposing Periodontitis: a potential risk factor for Alzheimer's disease.Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study.Predicting New Target Conditions for Drug Retesting Using Temporal Patterns in Clinical Trials: A Proof of Concept.DrugSig: A resource for computational drug repositioning utilizing gene expression signatures.An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.Emerging amyloid and tau targeting treatments for Alzheimer's disease.Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.Target Fishing by Cross-Docking to Explain Polypharmacological Effects

P2860

Q26747572-C3AC0324-F054-4E7A-B6EB-64676C5E095F Q26748728-5C002026-BA23-4C9D-8D87-CD362FD79941 Q26799870-9002D625-6E36-40FC-89FB-AFC5BA672B0B Q28548306-A3673B76-EA06-4231-97BB-45F36EDAB987 Q34667418-37FF43EA-E5EA-4F17-97AB-21AA950B8F3A Q35575400-16B4E19A-E0FC-48A8-911D-A42B0E5C26C8 Q35917213-C6B61D88-4524-44E3-9B1B-95D03979713A Q36386321-E1368081-CF6B-4891-953D-DFC080567261 Q36593553-8C4F11D2-C84F-427C-B20A-A6F63DA4559C Q39296311-542E7D5E-B100-4113-865D-2AE51160351C Q39296351-B7B77EC5-2882-49F2-AC58-D4959274C739 Q55190915-3B5076D0-B8E7-4816-B932-A85955996E95 Q57010613-7F00E194-5E8A-470A-A6E6-DA4FBD80EFC5

P2860

Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

http://www.wikidata.org/entity/Q37279999

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

@en

Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

@nl

type

label

Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

@en

Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

@nl

prefLabel

Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

@en

Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

@nl

P1433

Q37279999-E7A4B75C-3282-4892-8F84-416650B217B7

P1476

Q37279999-431C808E-5CE3-4C86-AA70-6ED4C355A3B6

P2860

Q37279999-0159E2D8-ADF6-47E3-BEA8-FFDA51E895A3

Q37279999-0722137C-556D-453F-B88E-7EE4F3EAF082

Q37279999-08A5619C-836A-479F-9293-0351D5E9031F

Q37279999-0EA5F86F-EB03-4110-AE8C-A1BBF2C26DDB

Q37279999-0EBDA793-E88B-41D7-A707-3A7376FD4537

Q37279999-10C4DCC6-278B-4660-BFDF-F4C0BA2E9451

Q37279999-138B8671-6CBD-460A-8B1D-3CE37D727C46

Q37279999-13DE8FA9-02F3-4B5B-92F2-BAEDDB0A48C6

Q37279999-15E19049-0844-4D3E-B3FA-7161E41C0E43

Q37279999-1738431A-DE60-427C-A7CA-1C195BE3260C

P304

Q37279999-898741FE-75D4-4202-8934-F2604EC4B5B8

P31

Q37279999-9C999883-7CD8-4809-B3D3-00513A067416

P356

Q37279999-FC4850E9-FFCE-4A7F-B1B8-83FEC6CB6303

P433

Q37279999-4082DA6E-6B99-4667-B9E8-D050FDAF03E7

P478

Q37279999-772F712A-76D3-4372-A78A-D2B6742A50C2

P50

Q37279999-00E84D75-FA90-4AEB-9A2E-3429C19FDB6C

Q37279999-AA31433C-A8BC-472F-A93C-A0D20BE75527

Q37279999-AD263B89-B50D-45ED-B531-383D30D2C573

P577

Q37279999-84B7FFD4-A765-4575-BC5E-56AF176765FB

P5875

Q37279999-CC8EA069-4065-4AC3-8E62-DCC02101C72D

P698

Q37279999-62C90C43-1394-4D6D-B70E-4006989E50F2

P921

Q37279999-D2BF5710-3744-41AC-8572-A5E53121E4AB

P932

Q37279999-789545B0-F81E-4839-8B08-7C35E99AE4CB

P356

P1433

Pharmaceuticals

P1476

Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

@en

P2860

Metal protein attenuating compounds for the treatment of Alzheimer's dementia

Metal protein attenuating compounds for the treatment of Alzheimer's disease

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

Apigenin and related compounds stimulate adult neurogenesis. Mars, Inc., the Salk Institute for Biological Studies: WO2008147483

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Drug repositioning: identifying and developing new uses for existing drugs

P304

1304-1321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PH6101304

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Gareth Williams

P577

2013-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258922000

http://www.w3.org/2001/XMLSchema#string

P698

24275851

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3817602

http://www.w3.org/2001/XMLSchema#string